The abstract does not include the specifics for these endpoints, only stating that there were significant improvements. Eli Lilly previously disclosed in a press release, that they expected patients using tirzepatide to lose between 18-20% of their body weight
Helps Patients Choosing the right GLP-1 treatment can feel confusing
This effect is more prominent in cells under continuous tamoxifen treatment
Safety and tolerability were consistent with adult phase 3 data and GLP-1 receptor agonists in general, Weghuber said
Quality & Handling Manufactured to pharmaceutical standards and packaged to maintain integrity during storage and transport
Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of heart problems (like a heart attack or stroke), or death in patients with type 2 diabetes mellitus (also known as type heart attack, stroke, or death in patients with type 2 diabetes)